DACT3

DACT3 is a negative regulator of canonical Wnt/β-catenin signaling that restrains pathway activity by physically interacting with Dishevelled proteins (DVL1, DVL2) and promoting their downregulation, thereby preventing GSK-3β inactivation, reducing active β-catenin accumulation and nuclear translocation, and attenuating downstream Wnt target gene expression (PMID:23580654, PMID:40838391, PMID:35187752). Genetic knockout in mice amplifies Wnt/β-catenin signaling and exacerbates renal fibrosis after ureteral obstruction, and epistasis experiments in leukemia cells confirm that DVL2 overexpression reverses DACT3-mediated Wnt suppression (PMID:23580654, PMID:35187752). DACT3 is epigenetically silenced in colorectal and hematologic cancers through bivalent histone modifications (H3K27me3/H3K4me3) and HDAC-dependent mechanisms; combined inhibition of histone methylation and deacetylation restores DACT3 expression, suppresses Wnt signaling, and induces apoptosis (PMID:18538736, PMID:35794797). Butyrate produced by gut commensals also upregulates DACT3 in intestinal epithelial cells, mediating anti-inflammatory effects via the Wnt/JNK pathway (PMID:33054518).

1. 2008 High

   The foundational discovery that DACT3 negatively regulates Wnt/β-catenin signaling and is itself epigenetically silenced in colorectal cancer through bivalent histone marks established DACT3 as both a Wnt pathway inhibitor and an epigenetically controlled tumor suppressor.

   Evidence Chromatin immunoprecipitation for bivalent histone marks, combined histone methylation/HDAC inhibitor treatment, luciferase Wnt reporter, and apoptosis assays in colorectal cancer cells

   PMID:18538736

   Open questions at the time

   • Direct physical binding partner within the Wnt pathway was not identified
   • Mechanism of DACT3-mediated Wnt inhibition (e.g., Dvl degradation vs. sequestration) was not resolved
   • Whether bivalent chromatin silencing is specific to colorectal cancer or generalizable was unknown
2. 2013 High

   Demonstration that DACT3 physically interacts with DVL2 and that genetic knockout amplifies Wnt signaling and worsens renal fibrosis in vivo established DACT3 as a physiologically relevant DVL-binding Wnt inhibitor.

   Evidence Dact3 conditional knockout mouse (EIIa-Cre), co-immunoprecipitation of Dact3–Dvl2, Topflash reporter, EMT assays in primary renal tubular cells, and unilateral ureteral obstruction fibrosis model

   PMID:23580654

   Open questions at the time

   • The binding domain on DACT3 or DVL2 mediating the interaction was not mapped
   • Whether DACT3 promotes DVL2 degradation or merely inhibits its activity was not distinguished
   • Contribution of non-canonical Wnt pathways to the fibrosis phenotype was not assessed
3. 2017 Medium

   Identification of miR-638 as a direct suppressor of DACT3 expression linked post-transcriptional regulation of DACT3 to autophagy and malignant phenotypes in esophageal and breast cancers.

   Evidence miRNA target prediction with experimental validation, siRNA-mediated DACT3 depletion phenocopying miR-638 effects, autophagy and cancer phenotype assays in vitro and in vivo

   PMID:28108314

   Open questions at the time

   • Direct luciferase 3′UTR reporter confirmation of miR-638 binding site was not shown in detail
   • Mechanism linking DACT3 loss to autophagy induction was not elucidated
   • Whether miR-638–DACT3 axis operates through canonical Wnt or alternative pathways was unresolved
4. 2020 Medium

   Placing DACT3 downstream of microbial butyrate in the intestinal Wnt/JNK pathway revealed a role for DACT3 in mediating gut commensal anti-inflammatory signaling.

   Evidence RNA-seq of butyrate-treated HT-29 cells, siRNA silencing of DACT3 abrogating anti-inflammatory effects of F. prausnitzii supernatant, in vivo mouse model

   PMID:33054518

   Open questions at the time

   • Whether butyrate acts on the DACT3 promoter via HDAC inhibition or through other transcriptional mechanisms was not resolved
   • Downstream effectors between DACT3 and the anti-inflammatory phenotype were not identified
   • Role of non-canonical Wnt/JNK versus canonical Wnt/β-catenin in this context was not delineated
5. 2022 Medium

   Epistasis experiments in AML cells demonstrated that DVL2 overexpression reverses DACT3-mediated Wnt suppression, confirming that DACT3 acts upstream of DVL2 in the canonical Wnt cascade, while HDAC inhibitor studies in lymphoma and myeloma extended the epigenetic silencing mechanism to hematologic malignancies.

   Evidence DACT3/DVL2 co-overexpression epistasis with TCF/LEF reporter and xenograft models in AML; HDAC inhibitor CKD-581 treatment with DACT3/β-catenin/c-Myc Western blots and apoptosis assays in T-cell lymphoma and myeloma

   PMID:35187752 PMID:35794797

   Open questions at the time

   • Whether DACT3 promotes DVL2 proteasomal or lysosomal degradation was not determined
   • Specificity of HDAC isoforms responsible for DACT3 repression was not identified
   • In vivo genetic validation in hematologic malignancy models is lacking
6. 2025 High

   Demonstration that DACT3 physically binds DVL1 and suppresses specific phosphorylation events (GSK-3β Ser9, β-catenin Ser675) clarified the proximal biochemical mechanism by which DACT3 prevents β-catenin nuclear translocation.

   Evidence Co-immunoprecipitation of DACT3–DVL1, immunofluorescence for β-catenin nuclear translocation, phospho-specific Western blots, luciferase Wnt reporter, gain- and loss-of-function in NSCLC cells

   PMID:40838391

   Open questions at the time

   • Structural basis of the DACT3–DVL1 interaction and whether it differs from the DACT3–DVL2 interaction is unknown
   • Whether DACT3 directly inhibits DVL kinase-scaffolding activity or promotes DVL degradation was not resolved
   • Relative contributions of DVL1 versus DVL2 inhibition to DACT3's tumor-suppressive function are untested

• The precise biochemical mechanism by which DACT3 downregulates Dishevelled proteins — whether through promoting ubiquitin-dependent degradation, sequestration, or direct inhibition of DVL scaffolding activity — remains unresolved, as does the structural basis of the DACT3–DVL interaction.
• No structural or domain-mapping data for the DACT3–DVL interaction exist
• Degradation versus sequestration mechanism for DVL downregulation has not been distinguished
• Physiological roles of DACT3 outside of Wnt-dependent contexts (e.g., Notch crosstalk, autophagy) lack rigorous genetic validation